266 related articles for article (PubMed ID: 8623929)
1. Induction of Heymann nephritis with a gp330/megalin fusion protein.
Raychowdhury R; Zheng G; Brown D; McCluskey RT
Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
[TBL] [Abstract][Full Text] [Related]
2. Detection of two forms of GP330. Their role in Heymann nephritis.
Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
[TBL] [Abstract][Full Text] [Related]
3. Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein.
Orlando RA; Kerjaschki D; Farquhar MG
J Am Soc Nephrol; 1995 Jul; 6(1):61-7. PubMed ID: 7579071
[TBL] [Abstract][Full Text] [Related]
4. Role of receptor-associated 39/45 kD protein in active Heymann nephritis.
Huang J; Makker SP
Kidney Int; 1995 Feb; 47(2):432-41. PubMed ID: 7723231
[TBL] [Abstract][Full Text] [Related]
5. The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
Farquhar MG; Saito A; Kerjaschki D; Orlando RA
J Am Soc Nephrol; 1995 Jul; 6(1):35-47. PubMed ID: 7579068
[TBL] [Abstract][Full Text] [Related]
6. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.
Tsukada Y; Ono K; Maezawa A; Yano S; Naruse T
Clin Exp Immunol; 1994 May; 96(2):303-10. PubMed ID: 8187338
[TBL] [Abstract][Full Text] [Related]
7. All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis.
Yamazaki H; Ullrich R; Exner M; Saito A; Orlando RA; Kerjaschki D; Farquhar MG
J Am Soc Nephrol; 1998 Sep; 9(9):1638-44. PubMed ID: 9727372
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330.
Pietromonaco S; Kerjaschki D; Binder S; Ullrich R; Farquhar MG
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1811-5. PubMed ID: 2408041
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a 330-kDa glycoprotein from human kidney similar to the Heymann nephritis autoantigen (gp330).
Kanalas JJ; Makker SP
J Am Soc Nephrol; 1990 Nov; 1(5):792-8. PubMed ID: 2133428
[TBL] [Abstract][Full Text] [Related]
10. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
[TBL] [Abstract][Full Text] [Related]
11. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein.
Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG
J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311
[TBL] [Abstract][Full Text] [Related]
12. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
Makker SP; Tramontano A
J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
[TBL] [Abstract][Full Text] [Related]
13. A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease.
Oleinikov AV; Feliz BJ; Makker SP
J Am Soc Nephrol; 2000 Jan; 11(1):57-64. PubMed ID: 10616840
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
Susani M; Schulze M; Exner M; Kerjaschki D
Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical and biochemical characterization of the Heymann nephritis antigenic complex in rat L2 yolk sac cells.
Lundstrom M; Orlando RA; Saedi MS; Woodward L; Kurihara H; Farquhar MG
Am J Pathol; 1993 Nov; 143(5):1423-35. PubMed ID: 8238258
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
Kerjaschki D; Farquhar MG
J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
[TBL] [Abstract][Full Text] [Related]
17. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
[TBL] [Abstract][Full Text] [Related]
18. Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis.
Makker SP
J Immunol; 1993 Dec; 151(11):6500-8. PubMed ID: 8245481
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.
Kerjaschki D; Exner M; Ullrich R; Susani M; Curtiss LK; Witztum JL; Farquhar MG; Orlando RA
J Clin Invest; 1997 Nov; 100(9):2303-9. PubMed ID: 9410908
[TBL] [Abstract][Full Text] [Related]
20. A novel autoantibody to plasminogen and its characterization in Heymann nephritis.
Makker SP
Clin Immunol Immunopathol; 1994 Jul; 72(1):105-13. PubMed ID: 8020183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
